PMID- 36553143 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20230308 IS - 2075-4418 (Print) IS - 2075-4418 (Electronic) IS - 2075-4418 (Linking) VI - 12 IP - 12 DP - 2022 Dec 12 TI - Retinal and Visual Pathways Involvement in Carriers of Friedreich's Ataxia. LID - 10.3390/diagnostics12123135 [doi] LID - 3135 AB - Friedreich's ataxia (FRDA) is a rare autosomal recessive neurodegenerative disorder due to the homozygous pathological expansion of guanine-adenine-adenine (GAA) triplet repeats in the first intron of the FXN gene, which encodes for the mitochondrial protein frataxin. In the visual system, the typical manifestations are ocular motility abnormality, optic neuropathy, and retinopathy. Despite the evidence of ophthalmological impairment in FRDA patients, there is a lack of information about the morpho-functional condition of the retina and of the optic pathways in healthy heterozygous carriers of Friedreich's ataxia (C-FRDA). Ten C-FRDA subjects (providing 20 eyes) and thirty-five Controls (providing 70 eyes) underwent a complete neurological and ophthalmological examination comprehensive of functional (full-field Electroretinogram (ffERG), multifocal Electroretinogram (mfERG), Visual Evoked Potential (VEP), and Pattern Reversal Electroretinogram (PERG)) and morphological assessments (Optical Coherence Tomography, OCT) of the retina, macula, retinal ganglion cells, and visual pathways. The groups' data were compared using a two-sample t-test. Pearson's test was used to investigate the morpho-functional correlations. Statistically significant differences (p < 0.01) between C-FRDA and Control eyes for the values of the following parameters were found: ffERG b-wave amplitude, mfERG Response Amplitude Densities, PERG P50 implicit time and P50-N95 amplitude, VEP P100 implicit time, Retinal Nerve Fiber Layer (RNFL) Overall, and Nasal thickness. The values of the OCT macular volume were not statistically different (p > 0.01) between the two Groups. Therefore, our data suggest that, in C-FRDA, a dysfunction of retinal elements without morphological macular impairment may occur. In addition, a morphological impairment of RNFL associated with an abnormal neural conduction along the visual pathways can be also detected. FAU - Ziccardi, Lucia AU - Ziccardi L AUID- ORCID: 0000-0002-5563-1243 AD - IRCCS-Fondazione Bietti, Via Livenza 1, 00198 Rome, Italy. FAU - Barbano, Lucilla AU - Barbano L AD - IRCCS-Fondazione Bietti, Via Livenza 1, 00198 Rome, Italy. FAU - Antonelli, Giulio AU - Antonelli G AUID- ORCID: 0000-0002-5200-6071 AD - IRCCS-Fondazione Bietti, Via Livenza 1, 00198 Rome, Italy. FAU - Cioffi, Ettore AU - Cioffi E AUID- ORCID: 0000-0002-9720-1065 AD - Department of Medical and Surgical Sciences and Biotechnologies, Sapienza University of Rome, 00185 Rome, Italy. FAU - Di Renzo, Antonio AU - Di Renzo A AD - IRCCS-Fondazione Bietti, Via Livenza 1, 00198 Rome, Italy. FAU - Gioiosa, Valeria AU - Gioiosa V AD - Department of Medical and Surgical Sciences and Biotechnologies, Sapienza University of Rome, 00185 Rome, Italy. FAU - Marcotulli, Christian AU - Marcotulli C AD - Department of Medical and Surgical Sciences and Biotechnologies, Sapienza University of Rome, 00185 Rome, Italy. FAU - Grzybowski, Andrzej AU - Grzybowski A AUID- ORCID: 0000-0002-3724-2391 AD - Department of Ophthalmology, University of Warmia and Mazury, Michala Oczapowskiego 2, 10455 Olsztyn, Poland. AD - Institute for Research in Ophthalmology, Foundation for Ophthalmology Development, Mickiewicza 24/3B, 60-836 Poznan, Poland. FAU - Casali, Carlo AU - Casali C AD - Department of Medical and Surgical Sciences and Biotechnologies, Sapienza University of Rome, 00185 Rome, Italy. FAU - Parisi, Vincenzo AU - Parisi V AD - IRCCS-Fondazione Bietti, Via Livenza 1, 00198 Rome, Italy. LA - eng PT - Journal Article DEP - 20221212 PL - Switzerland TA - Diagnostics (Basel) JT - Diagnostics (Basel, Switzerland) JID - 101658402 PMC - PMC9777201 OTO - NOTNLM OT - ERG OT - Friedreich OT - OCT OT - PERG OT - VEP OT - ataxia OT - carriers OT - mfERG COIS- The authors declare no conflict of interest. EDAT- 2022/12/24 06:00 MHDA- 2022/12/24 06:01 PMCR- 2022/12/12 CRDT- 2022/12/23 01:19 PHST- 2022/11/12 00:00 [received] PHST- 2022/12/07 00:00 [revised] PHST- 2022/12/08 00:00 [accepted] PHST- 2022/12/23 01:19 [entrez] PHST- 2022/12/24 06:00 [pubmed] PHST- 2022/12/24 06:01 [medline] PHST- 2022/12/12 00:00 [pmc-release] AID - diagnostics12123135 [pii] AID - diagnostics-12-03135 [pii] AID - 10.3390/diagnostics12123135 [doi] PST - epublish SO - Diagnostics (Basel). 2022 Dec 12;12(12):3135. doi: 10.3390/diagnostics12123135.